Skip to content
healthcare.dev

Avanafil

NDC 31722-440, Avanafil, tablet, from Camber Pharmaceuticals, Inc..

Product NDC
31722-440
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209266
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-440 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AVANAFIL50 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
31722-440-0131722044001100 TABLET in 1 BOTTLE (31722-440-01)
31722-440-303172204403030 TABLET in 1 BOTTLE (31722-440-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1d04e17d-7399-430a-a8bb-fa1912b155e9

Use it

Look up 31722-440 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-440 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-440. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.